US EditionMexico Advances in Biotechnology: Ipn Works in Vaccines for Chikungunya and Yellow Fever
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
CDMX.- The National Polytechnic Institute (IPN) investigates and develops vaccine candidates against chikungunya and yellow fever based on non-replicative adenoviral vectors, which represents a remarkable advance in Mexico’s scientific sovereignty. The project is coordinated by Dr. María Isabel Salazar Sánchez, director of the National Laboratory of Tuberculosis and Tropical Viruses, which has been operating since July 2023 with funding from the…
Gustavo PachecoThe National Laboratory of Tuberculosis and Tropical Viruses of the National Polytechnic Institute (IPN) develops vaccine candidates against tropical diseases such as chikungunya and yellow fever, based on non-replicative adenoviral vectors.These advances place Mexico within the new generation of biotechnologies that seek to strengthen scientific sovereignty and respond quickly to emerging viruses.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
